Galveston, TX, United States of America

Helen Hellmich

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helen Hellmich. Retrieved from https://idiyas.com/inventor/helen-hellmich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,708 
Other
 patents

Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Helen Hellmich

Introduction

Helen Hellmich is a notable inventor based in Galveston, TX (US). She has made significant contributions to the field of pain management through her innovative research and development. Her work focuses on identifying compounds that can effectively decrease pain in subjects.

Latest Patents

Helen holds a patent for a method of identifying antinociceptive compounds using protease activated receptor-2. This invention provides a method of decreasing pain in a subject by administering a compound that effectively reduces the activation of protease activated receptor-2. This patent highlights her commitment to advancing medical science and improving patient care.

Career Highlights

Throughout her career, Helen has demonstrated a strong dedication to research and innovation. Her work has the potential to impact the lives of many individuals suffering from pain-related conditions. With her expertise, she continues to explore new avenues for pain relief.

Collaborations

Helen has collaborated with talented individuals such as Maria-Adelaide Micci and Mohan Shenoy. These partnerships have allowed her to expand her research and contribute to the scientific community.

Conclusion

Helen Hellmich's innovative work in pain management exemplifies the importance of research and development in healthcare. Her contributions are paving the way for new treatments and improving the quality of life for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…